Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccineJoseph P. Casazza, Anita Arthur, Nina M. Berkowitz et al.|npj Vaccines|2024Cited by 22